Chiara Lobetti Bodoni

436 total citations
8 papers, 194 citations indexed

About

Chiara Lobetti Bodoni is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Chiara Lobetti Bodoni has authored 8 papers receiving a total of 194 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 5 papers in Oncology and 3 papers in Genetics. Recurrent topics in Chiara Lobetti Bodoni's work include Lymphoma Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Chiara Lobetti Bodoni is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Chiara Lobetti Bodoni collaborates with scholars based in Italy, United States and France. Chiara Lobetti Bodoni's co-authors include Marco Ladetto, Corrado Tarella, Mario Boccadoro, Irene Ricca, Daniela Drandi, Monica Astolfi, Sara Cresta, Gianluca Gaïdano, Pietro Bulian and Francesca Maria Rossi and has published in prestigious journals such as Blood, Leukemia and Haematologica.

In The Last Decade

Chiara Lobetti Bodoni

8 papers receiving 192 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Lobetti Bodoni Italy 6 116 105 67 47 33 8 194
F Davi France 6 115 1.0× 118 1.1× 68 1.0× 93 2.0× 20 0.6× 8 262
Barbara Mantoan Italy 7 106 0.9× 53 0.5× 71 1.1× 11 0.2× 20 0.6× 13 155
Sarah H. Walsh Sweden 8 224 1.9× 211 2.0× 107 1.6× 59 1.3× 13 0.4× 9 289
Veronika Navrkalová Czechia 8 97 0.8× 121 1.2× 47 0.7× 61 1.3× 7 0.2× 18 217
Andrea Schnaiter Germany 7 79 0.7× 112 1.1× 42 0.6× 59 1.3× 6 0.2× 18 183
Dominique Boulet France 6 177 1.5× 157 1.5× 87 1.3× 46 1.0× 34 1.0× 10 301
Cyrus Khan United States 11 151 1.3× 50 0.5× 181 2.7× 28 0.6× 16 0.5× 44 275
Sujaatha Narayanan Canada 10 63 0.5× 81 0.8× 61 0.9× 40 0.9× 19 0.6× 43 272
Mia Thorsélius Sweden 6 206 1.8× 230 2.2× 65 1.0× 109 2.3× 10 0.3× 8 268
Jan Konrad Siwicki Poland 10 76 0.7× 34 0.3× 73 1.1× 39 0.8× 37 1.1× 25 260

Countries citing papers authored by Chiara Lobetti Bodoni

Since Specialization
Citations

This map shows the geographic impact of Chiara Lobetti Bodoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Lobetti Bodoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Lobetti Bodoni more than expected).

Fields of papers citing papers by Chiara Lobetti Bodoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Lobetti Bodoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Lobetti Bodoni. The network helps show where Chiara Lobetti Bodoni may publish in the future.

Co-authorship network of co-authors of Chiara Lobetti Bodoni

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Lobetti Bodoni. A scholar is included among the top collaborators of Chiara Lobetti Bodoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Lobetti Bodoni. Chiara Lobetti Bodoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Salles, Gilles, Stephen J. Schuster, Martin Dreyling, et al.. (2022). Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma. Blood Advances. 6(22). 5835–5843. 26 indexed citations
2.
Salles, Gilles, Stephen J. Schuster, Martin Dreyling, et al.. (2021). Efficacy Comparison of Tisagenlecleucel Versus Standard of Care in Patients with Relapsed or Refractory Follicular Lymphoma. Blood. 138(Supplement 1). 3528–3528. 3 indexed citations
3.
4.
Ferrero, Simone, Luigia Monitillo, Barbara Mantoan, et al.. (2013). Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma. Annals of Hematology. 92(11). 1503–1511. 10 indexed citations
5.
Rossi, Davide, Antonella Zucchetto, Francesca Maria Rossi, et al.. (2008). CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia. Haematologica. 93(10). 1575–1579. 56 indexed citations
6.
7.
Ricca, Irene, Alberto Rocci, Daniela Drandi, et al.. (2007). Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients. Leukemia. 21(4). 697–705. 33 indexed citations
8.
Ladetto, Marco, Michele Magni, G Pagliano, et al.. (2006). Rituximab Induces Effective Clearance of Minimal Residual Disease in Molecular Relapses of Mantle Cell Lymphoma. Biology of Blood and Marrow Transplantation. 12(12). 1270–1276. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F Davi Breakdown of academic impact, for papers by Barbara Mantoan Breakdown of academic impact, for papers by Sarah H. Walsh Breakdown of academic impact, for papers by Veronika Navrkalová Breakdown of academic impact, for papers by Andrea Schnaiter Breakdown of academic impact, for papers by Dominique Boulet Breakdown of academic impact, for papers by Cyrus Khan Breakdown of academic impact, for papers by Sujaatha Narayanan Breakdown of academic impact, for papers by Mia Thorsélius Breakdown of academic impact, for papers by Jan Konrad Siwicki
Rankless by CCL
2026